Talpis, Alexa Diane .
HRN: 21-74-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/03/2022
08/10/2022
IV
250 Mg
Q6H
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes